FDA Investigator Bryan L Mcguckin

Bryan L Mcguckin has inspections in 7 countries as of 01 Sep 2023. Bryan L Mcguckin has collaborated with a combined 3587 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
78
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Canada, Germany, India, Taiwan, Korea (Republic of)
Co-Investigator(s):
Adam J Taylor, Adetutu M Gidado, Alecia L Marson, Alicia K Mckinsey, Amanda Dinaro, Amanda S Zorn, Amina Bashir, Anders W Evenson, Anita Narula, PhD, Anthony C Warchut, Anthony J Ladner, Arie C Menachem, Arsen Karapetyan, Ashar P Parikh, Audrey Dela Cruz, Binh T Nguyen, Bradley J Maunder, Brian D Nicholson, Brian P Emanuel, Brittany R Laymon, Bruce H Mccullough, Bryce H Thompson, Carl A Huffman, III, Carrie Ann Plucinski, Caryn M Everly, Caryn M Mcnab, Charles D Brown, Charles M Edwards, Chase S Baldwin, Christina A Miller, Christina K Theodorou, Christopher D Leach, Christopher M Jenner, Christopher R Czajka, Claire M Minden, Clotia Cabbey Mensah, Colleen M Jones, Comyar Shoghi, Crystal Monroy, Daniel B Arrecis, Dariusz Galezowski, David Perkins, Dawn E Barkans, Debra I Love, Debra L Boyd Seale, Denarvis C Mendenhall, Dennis Cantellops Paite, Deyaa Shaheen, Djamila Harouaka, Doan T Nguyen, PharmD, Dogbeda F Mackenzie, Don H Bark, PhD, Donald B Mckechnie, Dr. Carmelo Rosa, Eileen A Liu, Elizabeth L Holmes, Emilie E Kahn, Eric M Mueller, PharmD, Eric S Pittman, Eric S Rittman, Erin D Mccaffery, Farhana Khan, Frederick Razzaghi, Gam S Zamil, Gary C Pecic, Gene D Arcy, Gerard Pde Leon, Gregory R Dill, Guerlain Ulysse, Gunneet Kaur, Heika R Tait, Helen Verdel, Hugh Grimoldby, Ivan E Reyes, James K Ireland, James W Plucinski, Janae D Price, Janet A Rajan, Jason F Chancey, Jawaid Hamid, Jeanne J Chiu, Jeanne J Thai, Jeffrey P Raimondi, Jennifer A D'angelo, Jennifer C Adams, Jesse A Vazquez, Jill J Tillman, Joan A Loreng, Jocelyn C Turner, Joey V Quitania, Joseph A Morkunas, Joseph D Cooper, Joseph M Allen, Joshua M Adams, June P Page, Kaitlyn R Kornberg, Karen Emasley Joseph, Karen L Rothschild, Kathleen S Tormey, Kenneth O Gee, PhD, Kerry L Edwards, III, Kham Phommachanh, Ko U Min, Kristen D Jarell, Langer, Larry F Hallberg, Latoya A Griffith, Lauren A Crivellone, Laurie A Haxel, Lequita M Mayhew, Leslie D Hintz, Lewis K Antwi, Lillian S Wu, Lisa C Lewis, Lisa Hayka, Lisa T Michel, Lorelei S Jarrell, Maksim A Levenchuk, Marcellinus D Dordunoo, Marcia A Worley, Marcus A Goshen, Marcus F Yambot, Margaret Torres Vazquez, Maria Diaz, Marie Bbuen Bigornia, Mary Jeanet Mcgarry, Mei Chiung J Huang, Melinda Lee, Michael L Casner, Michael R Goga, Michael R Klapal, Michele L Glendenning, Michelle L Dragon, Min Chu Chen, Muralidhara B Gavini, PhD, Nadeem I Chaudhry, Nancy M Espinal, Nibin Varghese, MS, Nicholas F Lyons, Nicholas Fragedakis, Nicholas L Hunt, Nicholas P Diorio, Nicholas Z Lu, Nicole A Lloyd, Nicole S Williams, Norman K Starks, Pablo Alcantara, Patricia A Mcilroy, Patrick C Klotzbuecher, Patrick E Gainer, Paula P Demichael, Peng Zhou, Phung Thien Nguyen, Rajiv R Srivastava, Reba A Gates, Richard L Rutherford, Richmond K Yip, Roger F Zabinski, Rose Ljean Mary, Russell J Glapion, Russell K Riley, S Lori Brown, PhD MPH, Saied A Asbagh, Samina S Khan, Samuel A Hamblin, Samuel T Walker, Sangeeta M Khurana, PhD, Santos E Camara, Sarah A Hassas, Sarah Nwandiuko, Seneca D Toms, Sharna D Pratt, Sharon K Thoma, PharmD, Sharon Pratt, State Agency, Stephanie A Jameson, Stephen D Eich, Sullan, Sundy Ven, Susan D Yuscius, Susan P Bruederle, Taichun Qin, PhD, Tamil Arasu, PhD, That Q Dang, Thomas J Arista, Thomas W Nojek, Thunder N Dunkijacobs, Todd M Stankewicz, Todd Q Dang, Tracey L Harris, Tracy K Li, Ucheabuchi C Chudi Nwankwor, Uttaniti Limchumroon (Tom), Vioela J Caze, Virgilio F Pacio, CSO, Wayne D Mcgrath, William G Nelson, William V Millar, Youkeun Kim, Yumi J Hiramine, Yvins Dezan, Yvonne E Lozano, Zakaria I Ganiyu, Zerita White

Bryan L Mcguckin's Documents

Publish Date Document Type Title
January, 2020 FDA 483 Person and Covey - Form 483, 2020-01-30
November, 2018 FDA 483 Hiers Enterprises, LLC dba Northwest Compounding Pharmacy - Form 483, 2018-11-14
November, 2019 FDA 483 Portland Compounding Pharmacy LLC - Form 483, 2019-11-26
February, 2022 FDA 483 Gulbrandsen Technologies Inc - Form 483, 2022-02-16
January, 2020 FDA 483 Vege-Kurl Inc - Form 483, 2020-01-24
September, 2022 FDA 483 JPR Labs Private Limited - Form 483, 2022-09-16
September, 2018 FDA 483 Kumho Dental Pharmaceutical Co., Ltd. - Form 483, 2018-09-13
September, 2016 FDA 483 Baxter Healthcare Corporation - Form 483, 2016-09-28
October, 2019 FDA 483 Banner Pharmacy Services, LLC - Form 483, 2019-10-08
June, 2017 EIR DENTAL TECHNOLOGIES, INC. - EIR, 2017-06-29
August, 2018 EIR Green Pharmaceutical Co., Ltd. - EIR, 2018-08-31
January, 2019 FDA 483 Health Solutions Pharmacy Center Inc dba Professional Compounding Pharmacy - Form 483, 2019-01-28
June, 2019 FDA 483 First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy - Form 483, 2019-06-14
April, 2022 FDA 483 Sunny Pharmtech Inc. - Form 483, 2022-04-15
February, 2017 EIR American Blending & Filling Company, Inc. - EIR, 2017-02-16
September, 2016 FDA 483 Takeda Pharmaceuticals USA, Inc. - Form 483, 2016-09-09
August, 2018 FDA 483 Green Pharmaceutical Co., Ltd. - Form 483, 2018-08-31
August, 2023 FDA 483 Vetio Animal Health - Form 483, 2023-08-18
May, 2016 EIR Xttrium Laboratories, Inc. - EIR, 2016-05-25
December, 2017 FDA 483 Universal Beauty Products Inc - Form 483, 2017-12-04
September, 2022 FDA 483 MAKSON HEALTH CARE PRIVATE LIMITED - Form 483, 2022-09-29
March, 2019 FDA 483 ACRX Specialty Pharmacy Inc - Form 483, 2019-03-20
April, 2023 FDA 483 JD & SN Inc. - Form 483, 2023-04-04
August, 2019 FDA 483 Compound Preferred LLC - Form 483, 2019-08-01
April, 2018 FDA 483 Pharmedium Services, LLC - Form 483, 2018-04-11
May, 2017 FDA 483 Snyder Mark Drugs Roselle, Inc. d.b.a. Mark Drugs Pharmacy - Form 483, 2017-05-22
August, 2017 FDA 483 Carepoint Healthcare LLC dba Carepoint Pharmacy - Form 483, 2017-08-24
January, 2018 FDA 483 Techni Med, Inc. dba The Compounder - Form 483, 2018-01-26
November, 2023 FDA 483 Signature Formulations LLC - Form 483, 2023-11-22
September, 2023 FDA 483 Delpharm Montreal Inc. - Form 483, 2023-09-01
December, 2019 FDA 483 Western Chemical Inc. - Form 483, 2019-12-23
January, 2024 FDA 483 Episciences, Inc. - Form 483, 2024-02-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more